Trials / Unknown
UnknownNCT05790590
Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT
Comparison of Image Quality Between "Double Low Dose" Liver CT Using AI-based Iodine Boosting Reconstruction and Standard Contrast-enhanced Liver CT in Patients With Colorectal Cancer: Prospective, Randomized, Non-inferiority Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 176 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
In patients with malignancies, contrast-enhanced abdominal CT (hereafter abdominal CT) plays an important role in detecting carcinoma recurrence and assessing treatment response. In this study, we aim to investigate whether such a "double low" dose CT is feasible in patients with liver metastases of colorectal cancer using a vendor-agnostic artificial intelligence-based noise reduction and contrast enhancement software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Double low dose CT | Simultaneous reduction of both radiation dose and contrast media dose |
| DIAGNOSTIC_TEST | Standard dose CT | CT with standard radiation dose and contrast media dose |
Timeline
- Start date
- 2023-05-30
- Primary completion
- 2024-12-31
- Completion
- 2025-06-30
- First posted
- 2023-03-30
- Last updated
- 2023-06-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05790590. Inclusion in this directory is not an endorsement.